Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2006 (Vol. 26, No. 20)

Cercle de Mycologie de Mons

URL:users.skynet.be/deneyer.mycology/index2.htm
  • Awesome pictures
  • Language issue for non-speakers
Here’s a first for the column, as best I can recall, a site without an English translation. Hosted in Belgium and written at least partly in French, the “Cercle de Mycologie de Mons” is great for French-speaking mushroom enthusiasts. Come to think of it, the site is also great for non-French mushroom enthusiasts, which is why I present it here. The site contains the most impressive and extensive sets of mushroom pixs I have ever found. With over 1,800 images and over 1,000 species, the site will wow anyone with the diversity and quality of images presented. Is a picture worth a thousand words even if you don’t understand the language describing it? The answer here is definitely oui, oui.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »